DSC_6715
Saturday, January 31, 2026
17.1
C
Bengaluru
Hot topics
Digital Therapeutics: New Frontiers in Healthcare
“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale”
- Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi
Made in China Biotech Is Shaking Up Global Drug Innovation
The era of Chinese biotech as a mere imitator...
Winning Sales Organization
"Digital in Pharma" Special Issue. Invitation to DigiStorm2017, How to Create a Winning Sales Organization and DigiPharmaX. Avail Early Bird Discount - details inside.
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
In a bold move to strengthen its hepatology pipeline,...
Digital in Pharma and RoI – What and How to Measure Metrics that Matter
To be able to measure the RoI on digital in pharma, it is necessary to understand customers as individuals and create newer segmentation based on these needs and interests. This calls for the NextGen RCPA of data collection and personalized communications that engage customers, based on which pharma must create customer experiences that matter to them.
If your content does not scratch, where it itches the customers, digital or phygital, customers will not feel at home (comfortable, delighted, and wants more), which is what matters. Not a digital euphoria, which will soon die down as customers simply ignore it as they did when pharma launched a plethora of webinars.
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
Hot topics
IMS Health Market Reflection Report for July 2016
The Indian Pharmaceutical Market (IPM) was valued atRs. 10,025 crores in the month of July 2016 clocking a 14.7% growth over same period last year (SPLY). This was the first time ever the market crossed the 10,000 crore mark in a single month.
Don’t Do Digital for the Sake of Doing Digital
Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness.
The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy.
Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
Is Indian Pharma Singing Digital Without Lyrics?
A large part of the pharma houses continues to...
Digital in Pharma and RoI – What and How to Measure Metrics that Matter
To be able to measure the RoI on digital in pharma, it is necessary to understand customers as individuals and create newer segmentation based on these needs and interests. This calls for the NextGen RCPA of data collection and personalized communications that engage customers, based on which pharma must create customer experiences that matter to them.
If your content does not scratch, where it itches the customers, digital or phygital, customers will not feel at home (comfortable, delighted, and wants more), which is what matters. Not a digital euphoria, which will soon die down as customers simply ignore it as they did when pharma launched a plethora of webinars.
Deep Bhandari: Human capital holds the highest value for organizations
DigiStorm 2018 was held on 11 September at the Lalit Ashok in Bangalore. The event was headlined by Prabir Jha – President & Global Chief People Officer, Cipla. Deep Bhandari – Editorial Board Member, MedicinMan, gives us the highlights of the post-lunch session.
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
IQVIA vs. PharmaTrac: Indian Pharma Market Data
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Newsletter
Get important news delivered directly to your inbox and stay connected!